ALZNAlzamend Neuro Inc. Common Stock
1.560USD+2.63%Mkt Cap: 7.47M $P/E: —3d ago
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which deli…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap7.47M $
Enterprise Value7.10M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.77M $
Revenue/Share—
Last Price1.560 USD
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.87
PEG—
EV/EBITDA-0.82
EV/Revenue—
P/S—
P/B9.48
EPS (TTM)-2.80
EPS (Forward)-0.87
52W Range
0.840039% of range2.680
52W High2.680 USD
52W Low0.8400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1196.43%
ROA-421.88%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.07M $
CapEx (TTM)—
FCF Margin—
FCF Yield-63.93%
Net Debt-710.69K $
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity—
Current Ratio1.31
Quick Ratio0.53
Book Value/Sh0.1720 USD
Cash/Share0.1480 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:9
Split DateMay 12, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.00 USD
Upside (mean)+1566.7%
Target Range26.00 USD – 26.00 USD
# Analysts1
Ownership
Shares Out.4.79M
Float4.78M
Insiders2.68%
Institutions29.02%
Short Interest
Short Ratio0.9d
Short % Float4.96%
Short % Out.4.93%
Shares Short236.38K
Short (prev mo.)157.52K
Technical
SMA 501.304 (+19.7%)
SMA 2001.642 (-5.0%)
Beta0.19
S&P 52W Chg18.16%
Avg Vol (30d)57.83K
Avg Vol (10d)81.98K
Technical Indicators
RSI (14)65.3
MACD0.0766
MACD Signal0.0646
MACD Hist.+0.0119
BB Upper1.598 USD
BB Middle1.413 USD
BB Lower1.227 USD
BB Width26.32%
ATR (14)0.0900 USD
Vol Ratio (20d)5.13x